Adage Capital Partners’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.2M | Buy |
|
|||||
|
2025
Q1 | $39.2M | Buy |
|
|||||
|
2024
Q4 | $6.56M | Sell |
|
|||||
|
2024
Q3 | $5.6M | Hold |
|
|||||
|
2024
Q2 | $3.29M | Sell |
|
|||||
|
2024
Q1 | $3.85M | Hold |
|
|||||
|
2023
Q4 | $4.5M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $92.5M | Buy |
|
|||||
|
2022
Q4 | $54.7M | Buy |
|
|||||
|
2022
Q3 | $57.9M | Buy |
|
|||||
|
2022
Q2 | $47.2M | Buy |
|
|||||
|
2022
Q1 | $38.7M | Buy |
|
|||||
|
2021
Q4 | $40.4M | Sell |
|
|||||
|
2021
Q3 | $41.2M | Sell |
|
|||||
|
2021
Q2 | $52.4M | Sell |
|
|||||
|
2021
Q1 | $114M | Buy |
|
|||||
|
2020
Q4 | $77.7M | Buy |
|
|||||
|
2020
Q3 | $28.3M | Sell |
|
|||||
|
2020
Q2 | $33.4M | Buy |
|
|||||
|
2020
Q1 | $15.2M | Buy |
|
|||||
|
2019
Q4 | $1.06M | Sell |
|
|||||
|
2019
Q3 | $1.16M | Buy |
|